Literature DB >> 24632273

Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis.

Susan M Dusenbery1, Michael Jerosch-Herold2, Carsten Rickers3, Steven D Colan1, Tal Geva1, Jane W Newburger1, Andrew J Powell4.   

Abstract

OBJECTIVES: This study sought to analyze cardiac magnetic resonance (CMR) measurements of myocardial extracellular volume fraction (ECV) and late gadolinium enhancement (LGE) in children and young adults with congenital aortic stenosis (AS) to determine the extent of fibrosis and examine their association with aortic valve and ventricular function.
BACKGROUND: Patients with congenital AS frequently have impaired diastolic ventricular function and exercise capacity that may be related to myocardial fibrosis.
METHODS: A total of 35 patients with congenital AS (median age 16 years) and 27 normal control subjects (median age 16 years) were evaluated by CMR. ECV was calculated from pre- and post-gadolinium contrast T1 measurements of blood and myocardium, and the hematocrit.
RESULTS: ECV was significantly higher in AS patients than in normal subjects (median 0.27 [range 0.22 to 0.42] vs. 0.25 [range 0.18 to 0.27], p = 0.001). LGE was present in 8 (24%) of the AS patients. A higher ECV was correlated with echocardiographic indexes of diastolic dysfunction including a higher mitral E-wave z-score (r = 0.58, p = 0.002), E/septal E' z-score (r = 0.56, p = 0.003), E/mean E' z-score (r = 0.55, p = 0.003), and indexed left atrial volume (r = 0.56, p = 0.001). Other factors associated with an elevated ECV (>0.28) included a greater number of aortic valve interventions (p = 0.004) and a greater number of aortic valve balloon valvuloplasties (p = 0.003). ECV was not significantly associated with AS gradient, left ventricular mass, mass/volume ratio, or ejection fraction.
CONCLUSIONS: In young patients with AS, myocardial ECV is significantly elevated compared with control subjects and is associated with echocardiographic indexes of diastolic dysfunction. ECV measured by CMR may be a useful method for risk stratification and monitoring therapies targeting fibrosis.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  congenital aortic stenosis; magnetic resonance imaging; myocardial fibrosis

Mesh:

Year:  2014        PMID: 24632273     DOI: 10.1016/j.jacc.2013.11.066

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

Review 1.  Update on the Role of Cardiac Magnetic Resonance Imaging in Congenital Heart Disease.

Authors:  Prabhakar Rajiah; Animesh Tandon; Gerald F Greil; Suhny Abbara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

Review 2.  Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis, Prognosis, and Treatment of Infiltrative Cardiomyopathies.

Authors:  Praveen G Ranganath; Albree Tower-Rader
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

3.  Extracellular volume fraction in coronary chronic total occlusion patients.

Authors:  Yin Yin Chen; Wei Guo Zhang; Shan Yang; Hong Yun; Sheng Ming Deng; Cai Xia Fu; Meng Su Zeng; Hang Jin; Liang Guo
Journal:  Int J Cardiovasc Imaging       Date:  2015-05-19       Impact factor: 2.357

4.  Association between diffuse myocardial fibrosis and diastolic dysfunction in sickle cell anemia.

Authors:  Omar Niss; Robert Fleck; Fowe Makue; Tarek Alsaied; Payal Desai; Jeffrey A Towbin; Punam Malik; Michael D Taylor; Charles T Quinn
Journal:  Blood       Date:  2017-05-15       Impact factor: 22.113

5.  Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.

Authors:  Nadya Al-Wakeel-Marquard; Sanaz Rastin; Frédéric Muench; Darach O H-Ici; Sevim Yilmaz; Felix Berger; Titus Kuehne; Daniel R Messroghli
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-15       Impact factor: 2.357

Review 6.  Recent Advances and Trends in Pediatric Cardiac Imaging.

Authors:  Wadi Mawad; Luc L Mertens
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-02-21

7.  Mapping versus source methods for quantifying myocardial T1 in controls and in repaired tetralogy of Fallot: interchangeability and reproducibility in children.

Authors:  Christopher Z Lam; Joseph J Pagano; Deane Yim; Shi-Joon Yoo; Mike Seed; Lars Grosse-Wortmann
Journal:  Pediatr Radiol       Date:  2019-06-12

Review 8.  Myocardial factor revisited: The importance of myocardial fibrosis in adults with congenital heart disease.

Authors:  Craig S Broberg; Luke J Burchill
Journal:  Int J Cardiol       Date:  2015-04-10       Impact factor: 4.164

Review 9.  Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease.

Authors:  Alison K Schroer; W David Merryman
Journal:  J Cell Sci       Date:  2015-04-27       Impact factor: 5.285

Review 10.  Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

Authors:  Robert B Hinton
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.